Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MXCT | AZN | AMGN | GILD | BMY |
| Company | Maxcyte Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.0400 | 186.69 | 336.26 | 133.77 | 56.69 |
| High | 1.1200 | 186.70 | 337.94 | 134.65 | 57.05 |
| Low | 1.0100 | 184.70 | 333.47 | 132.69 | 56.10 |
| Latest | 1.0900 | 185.33 | 336.66 | 132.96 | 56.53 |
| Change | +0.0700 | -2.39 | +0.21 | -0.09 | +0.14 |
| % Change | +6.86% | -1.27% | +0.06% | -0.07% | +0.25% |
| Volume | 722,518 | 208,410 | 281,265 | 489,463 | 927,114 |
| 20-Day Average Volume | 869,088 | 2,020,967 | 2,598,295 | 6,051,917 | 9,830,257 |
| Previous Close | 1.0200 | 187.72 | 336.45 | 133.05 | 56.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8769 | 188.20 | 338.38 | 132.79 | 57.82 |
| 20-Day Raw Stochastic | 82.71% | 20.43% | 44.58% | 56.19% | 27.26% |
| 20-Day Relative Strength | 68.14 | 44.00 | 45.62 | 48.06 | 45.94 |
| Weighted Alpha | -43.54 | +27.72 | +19.07 | +26.12 | +21.62 |
| Today's Opinion | 24% Sell | 16% Sell | 24% Sell | 24% Buy | 8% Buy |
| Previous Opinion | 24% Sell | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Last Month's Opinion | 56% Sell | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +25.65% since 05/07/26 | +1.45% since 05/07/26 | +2.32% since 05/07/26 | +0.29% since 05/07/26 | +1.10% since 05/07/26 |
| Low | 0.7840 on 05/12/26 | 181.58 on 05/08/26 | 327.62 on 05/11/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 1.1600 on 05/13/26 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.02 on 05/12/26 |
| 1-Month | |||||
| %Chg | +24.23% since 04/14/26 | -9.40% since 04/14/26 | -4.05% since 04/14/26 | -4.27% since 04/14/26 | -2.08% since 04/14/26 |
| Low | 0.7840 on 05/12/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 1.1600 on 05/13/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +52.17% since 02/13/26 | -9.91% since 02/13/26 | -8.79% since 02/13/26 | -13.25% since 02/13/26 | -6.37% since 02/13/26 |
| Low | 0.6434 on 02/17/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 1.1600 on 05/13/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -30.70% since 11/14/25 | +3.91% since 11/14/25 | unch since 11/14/25 | +7.54% since 11/14/25 | +21.91% since 11/14/25 |
| Low | 0.6434 on 02/17/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 1.8050 on 11/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 109,264 | 291,136,448 | 181,577,024 | 165,190,896 | 115,152,384 |
| Shares Outstanding, K | 107,122 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 33,030,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -44,630,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 7,300,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -9,600,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.37 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 03/24/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/05/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.93 | 15.22 | 16.12 | 9.52 |